Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
It is the investigators understanding that the combination of clinical trial with laboratory
cellular/molecular assay is relevant to the current promising mainstream, the translational
research. The design of this trial fulfills this concept and would be a good example
conducting in Mackay Memorial hospital.